Stock comparison
LeMaitre Vascular
Waters
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
WAT
Waters
Market cap
$22.32B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | WAT | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 63C | LMAT |
| Benjamin Graham | 89A | 62C | LMAT |
| Philip Fisher | 81C | 60C | LMAT |
| Peter Lynch | 67B | 21F | LMAT |
| Joel Greenblatt | 56D | 48D | LMAT |
| Charlie Munger | 68D | 65C | LMAT |
| Terry Smith | 69D | 59C | LMAT |
Side-by-side metrics
| Metric | LMAT | WAT |
|---|---|---|
| Market cap | $2.23B | $22.32B |
| P/E (TTM) | 37.1x | 63.6x |
| EV/EBIT | 36.6x | 30.7x |
| ROIC (TTM) | 9.43% | 2.25% |
| Gross margin | 72.39% | 55.02% |
| Net margin | 24.35% | 11.91% |
| Revenue CAGR 5y | 12.75% | 3.24% |
| EPS CAGR 5y | 19.04% | -1.02% |
| Debt / Equity | 0.5x | 0.3x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- EPS CAGR 5y19.04%vs -1.02%+105%
- Dividend yield0.84%vs 0.0%+100%
- ROIC (TTM)9.43%vs 2.25%+76%
- Revenue CAGR 5y12.75%vs 3.24%+75%
WAT leads on
- Market cap$22.32Bvs $2.23B+90%
- Debt / Equity0.3xvs 0.5x+27%
- EV/EBIT30.7xvs 36.6x+16%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.